Trends of nontraumatic lower extremity amputation in end-stage renal disease and diabetes, United States, 2000-2015.
File(s)Harding_Amputations_ESRD_Diabetes_Care_2019.docx (65.96 KB)
Accepted version
Author(s)
Harding, Jessica L
Pavkov, Meda E
Gregg, Edward W
Burrows, Nilka R
Type
Journal Article
Abstract
OBJECTIVE: Nontraumatic lower extremity amputation (NLEA) is a complication of end-stage renal disease (ESRD) and diabetes. Although recent data show that NLEA rates in the U.S. ESRD population are declining overall, trends in diabetes and diabetes subgroups remain unclear. RESEARCH DESIGN AND METHODS: We estimated annual rates of NLEA hospitalizations during 2000-2015 among >2 million adults (≥18 years) with ESRD from the U.S. Renal Data System. Age, sex, and race-adjusted NLEA rates were stratified by diabetes status, age, sex, race, and level of amputation (toe, foot, below the knee, and above the knee). Time trends were assessed using Joinpoint regression with annual percent changes (APC) reported. RESULTS: Among adults with diabetes, NLEA rates declined 43.8% between 2000 and 2013 (from 7.5 to 4.2 per 100 person-years; APC -4.9, P < 0.001) and then stabilized. Among adults without diabetes, rates of total NLEAs declined 25.5% between 2000 and 2013 (from 1.6 to 1.1; APC -3.0, P < 0.001) and then stabilized. These trends appear to be driven by a slowing or stagnation in declines of minor NLEAs (toe and foot) in more recent years, while major NLEAs (above the knee) continue to decline. CONCLUSIONS: Despite an initial period of decline, this analysis documents a stall in progress in NLEA trends in recent years in a high-risk population with both ESRD and diabetes. Increased attention to preventive foot care in the ESRD population should be considered, particularly for those with diabetes.
Date Issued
2019-05-29
Date Acceptance
2019-05-07
Citation
Diabetes Care, 2019, 42 (7), pp.1-6
ISSN
0149-5992
Publisher
American Diabetes Association
Start Page
1
End Page
6
Journal / Book Title
Diabetes Care
Volume
42
Issue
7
Copyright Statement
© 2019 by the American Diabetes Association.
Readers may use this article as long as the work
is properly cited, the use is educational and not
for profit, and the work is not altered. More information is available at http://www.diabetesjournals
.org/content/license. This is an author-created, uncopyedited electronic version of an article accepted for publication in Diabetes Care. The American Diabetes Association (ADA), publisher of Diabetes Care, is not responsible for any errors or omissions in this version of the manuscript or any version derived from it by third parties. The definitive publisher-authenticated version will be available in a future issue of Diabetes Care in print and online athttps://doi.org/10.2337/dc19-0296.
Readers may use this article as long as the work
is properly cited, the use is educational and not
for profit, and the work is not altered. More information is available at http://www.diabetesjournals
.org/content/license. This is an author-created, uncopyedited electronic version of an article accepted for publication in Diabetes Care. The American Diabetes Association (ADA), publisher of Diabetes Care, is not responsible for any errors or omissions in this version of the manuscript or any version derived from it by third parties. The definitive publisher-authenticated version will be available in a future issue of Diabetes Care in print and online athttps://doi.org/10.2337/dc19-0296.
Identifier
https://www.ncbi.nlm.nih.gov/pubmed/31142496
PII: dc19-0296
Subjects
11 Medical and Health Sciences
Endocrinology & Metabolism
Publication Status
Published online
Coverage Spatial
United States
Date Publish Online
2019-05-29